"One-for-All" approach: a black technology for nanomedicine development?

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Drug Delivery Systems

Background:

• Current cancer nanomedicines offer limited therapeutic benefits, primarily managing side effects rather than improving survival rates.
• Existing nanomedicines struggle to overcome the complex biological barriers inherent in the drug delivery cascade.
• There is a critical need for nanocarriers with integrated, synchronized functions for enhanced cancer treatment.

Purpose of the Study:

• To review recent advancements in nanomedicine design strategies for cancer therapy.
• To discuss the All-in-One and One-for-All approaches for developing functional nanocarriers.
• To provide insights into future directions for nanomedicine development in oncology.

Main Methods:

• Literature review of current nanomedicine design strategies.
• Analysis of the All-in-One approach, integrating multiple functions into a single nanocarrier system.
• Examination of the One-for-All approach, utilizing a single functional group to achieve multiple therapeutic effects.

Main Results:

• The All-in-One approach integrates diverse functionalities within a single nanomedicine platform.
• The One-for-All approach leverages specific molecular affinities to enable multiple functions.
• Both strategies aim to overcome biological barriers for improved drug delivery.

Conclusions:

• Synchronized nanocarrier functions are essential for efficient drug delivery and enhanced therapeutic efficacy in cancer treatment.
• The All-in-One and One-for-All strategies represent key advancements in nanomedicine design.
• Future research should focus on optimizing these strategies for improved patient survival and clinical outcomes.